Extracorporeal immune cell therapy of sepsis: ex vivo results.

Gerd KlinkmannThomas WildBenjamin HeskampFanny DossSandra DossLubomir ArsenievKrasimira AleksandrovaMartin SauerDaniel A ReuterSteffen MitznerJens Altrichter

Published in: Intensive care medicine experimental (2022)

Results demonstrate the suitability of a simplified extracorporeal system. Furthermore, granulocytes remain viable and highly active during a 6-h treatment even after storage for 3 days supporting the treatment of septic patients with this system in advanced clinical trials.

Keyphrases

clinical trial
acute kidney injury
combination therapy
mesenchymal stem cells
replacement therapy
open label